208 related articles for article (PubMed ID: 11957264)
1. Experience with vincristine--associated neurotoxicity.
Othieno-Abinya NA; Nyabola LO
East Afr Med J; 2001 Jul; 78(7):376-8. PubMed ID: 11957264
[TBL] [Abstract][Full Text] [Related]
2. Vincristine neuropathy: neurophysiological and genetic studies in a case of Wilms tumor.
Schiavetti A; Frascarelli M; Uccini S; Novelli A
Pediatr Blood Cancer; 2004 Oct; 43(5):606-9. PubMed ID: 15382281
[TBL] [Abstract][Full Text] [Related]
3. Frequency, characteristics, and reversibility of peripheral neuropathy during treatment of advanced multiple myeloma with bortezomib.
Richardson PG; Briemberg H; Jagannath S; Wen PY; Barlogie B; Berenson J; Singhal S; Siegel DS; Irwin D; Schuster M; Srkalovic G; Alexanian R; Rajkumar SV; Limentani S; Alsina M; Orlowski RZ; Najarian K; Esseltine D; Anderson KC; Amato AA
J Clin Oncol; 2006 Jul; 24(19):3113-20. PubMed ID: 16754936
[TBL] [Abstract][Full Text] [Related]
4. Clinical and electrophysiological studies in vincristine induced neuropathy.
Pal PK
Electromyogr Clin Neurophysiol; 1999 Sep; 39(6):323-30. PubMed ID: 10499201
[TBL] [Abstract][Full Text] [Related]
5. Dose-related vincristine-induced peripheral neuropathy with unexpected off-therapy worsening.
Verstappen CC; Koeppen S; Heimans JJ; Huijgens PC; Scheulen ME; Strumberg D; Kiburg B; Postma TJ
Neurology; 2005 Mar; 64(6):1076-7. PubMed ID: 15781834
[TBL] [Abstract][Full Text] [Related]
6. Dysfunction in multiple primary afferent fiber subtypes revealed by quantitative sensory testing in patients with chronic vincristine-induced pain.
Dougherty PM; Cata JP; Burton AW; Vu K; Weng HR
J Pain Symptom Manage; 2007 Feb; 33(2):166-79. PubMed ID: 17280922
[TBL] [Abstract][Full Text] [Related]
7. Fulminant peripheral neuropathy with severe quadriparesis associated with vincristine therapy.
Moudgil SS; Riggs JE
Ann Pharmacother; 2000 Oct; 34(10):1136-8. PubMed ID: 11054980
[TBL] [Abstract][Full Text] [Related]
8. Vincristine-induced peripheral neuropathy in a neonate with congenital acute lymphoblastic leukemia.
Baker SK; Lipson DM
J Pediatr Hematol Oncol; 2010 Apr; 32(3):e114-7. PubMed ID: 20216233
[TBL] [Abstract][Full Text] [Related]
9. Vincristine neurotoxicity enhanced in combination chemotherapy including both teniposide and vincristine.
Griffiths JD; Stark RJ; Ding JC; Cooper IA
Cancer Treat Rep; 1986 Apr; 70(4):519-21. PubMed ID: 3009012
[TBL] [Abstract][Full Text] [Related]
10. Association of an inherited genetic variant with vincristine-related peripheral neuropathy in children with acute lymphoblastic leukemia.
Diouf B; Crews KR; Lew G; Pei D; Cheng C; Bao J; Zheng JJ; Yang W; Fan Y; Wheeler HE; Wing C; Delaney SM; Komatsu M; Paugh SW; McCorkle JR; Lu X; Winick NJ; Carroll WL; Loh ML; Hunger SP; Devidas M; Pui CH; Dolan ME; Relling MV; Evans WE
JAMA; 2015 Feb; 313(8):815-23. PubMed ID: 25710658
[TBL] [Abstract][Full Text] [Related]
11. Vincristine-induced neuropathy: Atypical electrophysiological patterns in children.
Courtemanche H; Magot A; Ollivier Y; Rialland F; Leclair-Visonneau L; Fayet G; Camdessanché JP; Péréon Y
Muscle Nerve; 2015 Dec; 52(6):981-5. PubMed ID: 25758843
[TBL] [Abstract][Full Text] [Related]
12. Modification of vincristine dosing during concomitant azole therapy in adult acute lymphoblastic leukemia patients.
Harnicar S; Adel N; Jurcic J
J Oncol Pharm Pract; 2009 Sep; 15(3):175-82. PubMed ID: 19282418
[TBL] [Abstract][Full Text] [Related]
13. Low dose vincristine-induced severe polyneuropathy in a Hodgkin lymphoma patient: a case report (vincristine-induced severe polyneuropathy).
Cil T; Altintas A; Tamam Y; Battaloğlu E; Isikdogan A
J Pediatr Hematol Oncol; 2009 Oct; 31(10):787-9. PubMed ID: 19770686
[TBL] [Abstract][Full Text] [Related]
14. Acute motor and sensory axonal neuropathy in Burkitt-like lymphoma.
Wanschitz J; Dichtl W; Budka H; Löscher WN; Boesch S
Muscle Nerve; 2006 Oct; 34(4):494-8. PubMed ID: 16671108
[TBL] [Abstract][Full Text] [Related]
15. Augmentation of vincristine neurotoxicity by irradiation of peripheral nerves.
Cassady JR; Tonnesen GL; Wolfe LC; Sallan SE
Cancer Treat Rep; 1980; 64(8-9):963-5. PubMed ID: 6256075
[TBL] [Abstract][Full Text] [Related]
16. Glutamate ameliorates experimental vincristine neuropathy.
Boyle FM; Wheeler HR; Shenfield GM
J Pharmacol Exp Ther; 1996 Oct; 279(1):410-5. PubMed ID: 8859020
[TBL] [Abstract][Full Text] [Related]
17. Long-term glutamate supplementation failed to protect against peripheral neurotoxicity of paclitaxel.
Loven D; Levavi H; Sabach G; Zart R; Andras M; Fishman A; Karmon Y; Levi T; Dabby R; Gadoth N
Eur J Cancer Care (Engl); 2009 Jan; 18(1):78-83. PubMed ID: 19473225
[TBL] [Abstract][Full Text] [Related]
18. Association of Paclitaxel pharmacokinetics with the development of peripheral neuropathy in patients with advanced cancer.
Mielke S; Sparreboom A; Steinberg SM; Gelderblom H; Unger C; Behringer D; Mross K
Clin Cancer Res; 2005 Jul; 11(13):4843-50. PubMed ID: 16000582
[TBL] [Abstract][Full Text] [Related]
19. The natural history of vincristine-induced laryngeal paralysis in children.
Kuruvilla G; Perry S; Wilson B; El-Hakim H
Arch Otolaryngol Head Neck Surg; 2009 Jan; 135(1):101-5. PubMed ID: 19153315
[TBL] [Abstract][Full Text] [Related]
20. Vincristine neurotoxicity.
Warrier RP; Tan T; Patel Y; Yu LC; Quarls K; Shenoy S
Indian Pediatr; 1992 Mar; 29(3):370-3. PubMed ID: 1319399
[No Abstract] [Full Text] [Related]
[Next] [New Search]
